TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,955,000 | +5582.1% | 8,700,000 | +5700.0% | 0.01% | – |
| Q3 2018 | $140,000 | -89.5% | 150,000 | -90.1% | 0.00% | -100.0% |
| Q1 2018 | $1,330,000 | +1411.4% | 1,513,000 | +1413.0% | 0.00% | – |
| Q4 2017 | $88,000 | -95.1% | 100,000 | -95.0% | 0.00% | -100.0% |
| Q3 2017 | $1,803,000 | +642.0% | 2,000,000 | +781.1% | 0.00% | – |
| Q2 2017 | $243,000 | -66.8% | 227,000 | -51.5% | 0.00% | -100.0% |
| Q4 2015 | $731,000 | +337.7% | 468,000 | +280.5% | 0.00% | – |
| Q3 2015 | $167,000 | +70.4% | 123,000 | +75.7% | 0.00% | – |
| Q2 2015 | $98,000 | -71.1% | 70,000 | -69.4% | 0.00% | – |
| Q1 2015 | $339,000 | +115.9% | 229,000 | +99.1% | 0.00% | – |
| Q4 2014 | $157,000 | +19.8% | 115,000 | +12.7% | 0.00% | – |
| Q3 2014 | $131,000 | +12.9% | 102,000 | -6.4% | 0.00% | – |
| Q4 2013 | $116,000 | +34.9% | 109,000 | +32.9% | 0.00% | – |
| Q2 2013 | $86,000 | – | 82,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |